Evidence map›Paper›PMID 38572501›Full record

ArticleClinical kidney journal2024

Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy.

George M Nassar, Robert Jameson, Steffi Sathiyaraj, Nayda Bidikian, Nelson Villasmil Hernandez, Sandeep Sahay

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical kidney journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

George M NassarHouston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.
Robert JamesonHouston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.
Steffi SathiyarajHouston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.
Nayda BidikianAmerican University of Beirut - Department of Internal Medicine, Beirut, Lebanon.
Nelson Villasmil HernandezHouston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.
Sandeep SahayHouston Methodist Hospital - Department of Internal Medicine, Houston, TX, USA.
Cornell University · USMethodist Hospital · USHarvard University · USHouston Methodist · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of renal failure in pulmonary hypertension (PH) is an ominous sign and implies excessive adverse hemodynamic factors. Pharmacologic agents to treat the PH are the mainstay of management, whereas diuretics assist in management of fluid overload. However, when such measures fail, dialysis and ultrafiltration (UF) become necessary to manage progressive azotemia and hypervolemia. Reversal of PH is essential to interrupt this vicious cycle of multisystem failure; otherwise, the need for renal replacement therapy would be permanent.

Indexed as

pulmonary hypertensionpulmonary thromboendarterectomyrenal failure

Identifiers

PMID38572501
PMCPMC10986204
OpenAlexW4392289040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.